Kim Askew to Risk Factors
This is a "connection" page, showing publications Kim Askew has written about Risk Factors.
Connection Strength
0.079
-
Alley WD, Burns C, Hartman ND, Askew K, Mahler SA. 3 for the Price of 1: Teaching Chest Pain Risk Stratification in a Multidisciplinary, Problem-based Learning Workshop. West J Emerg Med. 2018 May; 19(3):613-618.
Score: 0.022
-
Stopyra JP, Miller CD, Hiestand BC, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Riley RF, Russell GB, Hoekstra JW, Mahler SA. Validation of the No Objective Testing Rule and Comparison to the HEART Pathway. Acad Emerg Med. 2017 09; 24(9):1165-1168.
Score: 0.021
-
Riley RF, Miller CD, Russell GB, Harper EN, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Mahler SA. Cost analysis of the History, ECG, Age, Risk factors, and initial Troponin (HEART) Pathway randomized control trial. Am J Emerg Med. 2017 Jan; 35(1):77-81.
Score: 0.020
-
Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD. The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):195-203.
Score: 0.017